Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 15 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Parcharidou, Despoina  [Clear All Filters]
Journal Article
Efthimiadis, G. K., Pagourelias E. D., Parcharidou D., Gossios T., Kamperidis V., Theofilogiannakos E. K., et al. (2013).  Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.. Circ J. 77(9), 2366-74.
Ntelios, D., Efthimiadis G., Zegkos T., Didagelos M., Katopodi T., Meditskou S., et al. (2020).  Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy. Hellenic Journal of Cardiology.
Ntelios, D., Efthimiadis G., Zegkos T., Didagelos M., Katopodi T., Meditskou S., et al. (2020).  Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy.. Hellenic J Cardiol.
Dimitroulas, T., Giannakoulas G., Papadopoulou K., Karvounis H., Dimitroula H., Koliakos G., et al. (2010).  Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.. J Rheumatol. 37(5), 993-9.
Ntelios, D., Meditskou S., Efthimiadis G., Pitsis A., Nikolakaki E., Girtovitis F., et al. (2017).  Elevated plasma levels of miR-29a are associated with hemolysis in patients with hypertrophic cardiomyopathy. Clinica Chimica Acta. 471, 321 - 326.
Zegkos, T., Panagiotidis T., Parcharidou D., & Efthimiadis G. (2020).  Emerging concepts in arrhythmogenic dilated cardiomyopathy.. Heart Fail Rev.
Ntelios, D., Parcharidou D., Zegkos T., Paraskevaidis S., Manolakos E., Papoulidis I., et al. (2020).  The multiple faces of Danon disease.. Hellenic J Cardiol.
Parcharidou, D., Zegkos T., Ntelios D., Panagiotidis T., Katranas S., Siskos A., et al. (2020).  The natural history of hypertrophic cardiomyopathy in a large Mediterranean cohort.. J Cardiovasc Med (Hagerstown). 21(6), 428-434.
Efthimiadis, G., Zegkos T., Meditskou S., Karamitsos T., Manolakos E., Papoulidis I., et al. (2020).  A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype.. Hellenic J Cardiol.
Doumas, A., Zegkos T., Parcharidou D., Gossios T., Ntelios D., Chatzileontiadou S., et al. (2022).  A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report.. Hell J Nucl Med. 25(2), 216-219.
Efthimiadis, G. K., Pagourelias E., Zegkos T., Parcharidou D., Panagiotidis T., Arvanitaki A., et al. (2016).  An Overview of Pharmacotherapy in Hypertrophic Cardiomyopathy: Current Speculations and Clinical Perspectives.. Rev Cardiovasc Med. 17(3-4), 115-123.
Ntiloudi, D., Zegkos T., Bazmpani M. Anna, Parcharidou D., Panagiotidis T., Hadjimiltiades S., et al. (2017).  Pregnancy outcome in women with congenital heart disease: A single-center experience. Hellenic Journal of Cardiology.
Ntiloudi, D., Zegkos T., Bazmpani M. Anna, Parcharidou D., Panagiotidis T., Hadjimiltiades S., et al. (2017).  Pregnancy outcome in women with congenital heart disease: A single-center experience.. Hellenic J Cardiol.
Zegkos, T., Parcharidou D., Ntelios D., Efthimiadis G., & Karvounis H. (2018).  The Prognostic Implications of Two-Dimensional Speckle Tracking Echocardiography in Hypertrophic Cardiomyopathy: Current and Future Perspectives.. Cardiol Rev. 26(3), 130-136.
Zegkos, T., Ntelios D., Parcharidou D., Katranas S., Panagiotidis T., Rouskas P., et al. (2020).  The Prognostic Value of Left Atrial Deformation Parameters for Sudden Arrhythmic Events in Hypertrophic Cardiomyopathy.. J Am Soc Echocardiogr. 33(10), 1276-1277.e1.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.